Agenda - Signals Summit 2022

Friday, December 2, 2022

*Times listed are in Central Standard Time

Agenda
6:30 – 7:55 AM		Breakfast with Exhibits
7:55 – 8:00 AM		Welcome / Introduction / Opening Remarks Elad Anter
8:00 – 10:00 AM		SESSION I: FUNDAMENTALS OF ELECTRICAL PROPAGATION Moderator: Natasja de Groot and David Callans
8:00 – 8:15 AM		PRINCIPLES OF CARDIAC CONDUCTION DEDUCED FROM EXPERIMENTAL OBSERVATIONS Principles of cardiac conduction deduced from experimental observations. Andre Kleber
8:15 – 8:30 AM		MECHANISMS AND SIGNALS OF SLOW CONDUCTION IN THE HEART Mechanisms of conduction, in particular slow conduction and related electrograms signals based on theoretical simulations and electrocardiographic imaging. Yoram Rudy
8:30 – 8:45 AM		3D ACTIVATION IN REGIONS OF ELECTRICAL DISCONTINUITY Tri-dimensional conduction in infarct border zones. Bruce Smaill
8:45 – 9:00 AM		3D ACTIVATION IN AF Tri-dimensional activation patterns during SR and AF in humans. Vadim Fedorov
9:00 – 9:15 AM		CONTRIBUTION OF HETEROGENICITY IN REPOLARIZATION FOR ARRHYTHMOGENESIS Clinical significance, methods of measurements, and implications for therapy. Kevin Donahue
9:15 – 9:30AM		ELECTROGENESIS OF CARDIAC BIOPOTENTIALS New data on communication between neuronal cells via electrical conduction through the surrounding extracellular space. Kalyanam Shivkumar
9:30 – 10:00 AM		Panel Discussion with Q&A Session
10:00 – 10:15 AM		Coffee Break and Exhibits
10:15 AM – 12:30 PM		SESSION II: ELECTROGRAM RECORDING: CHALLENGES AND SOLUTIONS Moderator: Pascal Van Dessel and Warren Jackman
10:15 – 10:30 AM		UNIPOLAR, BIPOLAR, OMNIPOLAR, AND LAPLACIAN ELECROGRAMS Utilities, limitations, and potential opportunities. Pascal Van Dessel
10:30 – 10:45 AM		CHALLENGES IN ACCURATE MEASUREMENT OF ACTIVATION TIMES What are the ongoing clinical deficits? Warren Jackman
10:45 – 11:00 AM		TRANSLATING CONDUCTION VELOCITY MEASUREMENTS FROM 2D TO 3D Correlation between conduction velocity measured with EAM in 2D and actual conduction velocity measured in 3D Edward Vigmond
11:00 – 11:15 AM		METHODOLOGICAL CONSIDERATIONS IN MAPPING FIBRILLATORY RHYTHMS Electrograms, signal processing, and computational approaches. Omer Berenfeld
11:15 – 11:30 AM		INSIGHTS FROM HIGH-RES, HIGH-DENSITY MAPPING OF AF IN HUMANS The impact of high-resolution, high-density mapping in determining AF mechanism. Natasja de Groot
11:30 – 11:45 AM		MAPPING WITH PACING FORM MULTIPLE WAVEFRONT IMPROVES SUBSTRATE CHARECTERIZATION OF VT ISTHMUS SITES Wavefront directionality improves identification of ventricular tachycardia substrate: insights from personalized computational heart models Natalia Trayanova
11:45 – 12:00 PM		SIGNAL RECORDINGS: IDEAS TO IMPROVE CATHETER DESIGNS Optimal catheter designs for unmet mapping needs. Olaf Dössel
12:00 – 12:30 PM		Panel Discussion with Q&A Session
12:30 – 1:15 PM		Lunch and Exhibits
1:15 – 2:15 PM		SESSION III: MARK E. JOSEPHSON MEMORIAL LECTURE Moderator: Elad Anter and Natasja de Groot
1:15 – 1:45 PM		ELECTRICAL PROPAGATION IN VENTRICULAR FIBRILLATION Electrical propagation during VT initiation and maintenance: implications for therapy. Michel Haïssaguerre
1:45 – 2:15 PM		Panel Discussion with Q&A Session
2:15 – 4:15 PM		SESSION IV: EMERGING TECHNOLOGIES IN SIGNAL RECORDING AND MAPPING Moderators: David Haines, Peter Spector, and Edward Ciaccio
2:15 – 2:25 PM		IMPLEMENTING FILTERS TO IMPROVE SIGNAL RECORDINGS Techniques for implementing filters without sacrificing signal information. Featured Technology Disclosure: This review will feature technology manufactured by BioSig Technologies, Inc. Zach Koch
2:25 – 2:35 PM		NEAR FIELD DETECTION: RESOLVING LOCAL CONDUCTANCE IN THE SUBSTRATE New developments in signal processing and applications related to omnipolar configurations. Featured Technology Disclosure: This review will feature technology manufactured by Abbott. Steven Kim
2:35 – 2:45 PM		ROLE OF SPATIOTEMPORAL ELECTROGRAM PROPAGATION IN AF MAPPING Novel electrogram-based method for identifying critical AF sites. Featured Technology Disclosure: This review will feature technology manufactured by Volta Medical. Jérome Kalifa
2:45 – 2:55 PM		ELECTROGRAPHIC FLOW MAPPING IN PERSISTENT AF Identification of active AF sources and their discrimination from passive rotors using electrographic flow mapping (an Ablacon technology). David Haines
2:55 – 3:05 PM		A NEW MAPPING APPROACH FOR IMPROVED SCAR DETECTION Description of a new technology (NeuTrace) and related clinical experience. Andrea Natale
3:05 – 3:15 PM		MAPPING AND IDENTIFYING ABLATION TARGETS DURING AF Featured Technology Disclosure: This review will feature technology manufactured by Rhythmia (Boston Scientific) Decebal Gabriel Lațcu
3:15 – 3:45 PM		THE CHALLENGES OF AF MAPPING Putting it all together-AF mapping approaches in a historical and mechanistic context and relevance to meaningful advancements in AF mapping and ablation Peter Spector
3:45 – 4:15 PM		Panel Discussion with Q&A Session
4:15 – 4:30 PM		Break and Exhibits
4:30 – 5:30 PM		SESSION V: RECORDED CASES Moderators: Josef Kautzner, David Callans, and Elad Anter
		ABLATION APPROACH OF PERSISTENT AF WITH PFA Strategy, protocol, and endpoints. Pierre Jaïs
		CARDIAC NEUROMODULATION OF VASOVAGAL SYNCOPE Protocol, technique, and endpoints. José Carlos Pachón
		ALCOHOL ABLATION OF PVC/VT Miguel Valderrábano
5:30 – 6:30 PM		Cocktail Reception with Exhibits

Registration >>

Saturday, December 3, 2022

*Times listed are in Central Standard Time

Agenda
7:00 – 8:15 AM		Breakfast and Exhibits
8:15 – 9:45 AM		SESSION VI: COMPUTATIONAL MODELS AND SIGNAL ANALYSIS Moderators: Paul Wang, Edward Vigmond, and Edward Ciaccio
8:15 – 8:30 AM		COMPUTATIONAL APPROACHES FOR DIFFERENTIATING NEAR-FIELD FROM FAR-FIELD POTENTIALS New methods for identifying near-field potentials within multicomponent electrograms. Elad Anter
8:30 – 8:45 AM		COMPUTATIONAL MODELS OF AF TO GUIDE THERAPY Application techniques of deep learning applied to diagnosing and interpreting arrhythmias. Sanjiv Narayan
8:45 – 9:00 AM		STRATEGIES TO ADDRESS GAPS IN UNDERSTANDING ELECTRICAL SIGNALS FROM MAPPING, WEARABLE, AND IMPLANTABLE DEVICES Gaps and ongoing challenges in applying digital health data to therapy. Paul Wang
9:00 – 9:15 AM		DEEP LEARNING FOR RAPID CREATION OF CHAMBER GEOMETRY Chamber geometry and conduction properties. Featured Technology Disclosure: This review will feature technology manufactured by Biosense Webster. Meir Bar-Tal
9:15 – 9:45 AM		Panel Discussion with Q&A Session
9:45 – 10:00 AM		Coffee Break and Exhibits
10:00 – 12:00 PM		SESSION VII: ANATOMY, PHYSIOLOGY, AND PACING ABLATION Moderators: Kalyanam Shivkumar and David Haines
10:00 – 10:15 AM		ANATOMY AND ELECTROPHYSIOLOGY OF THE HIS–PURKINJE NETWORK The basis for its contribution to arrhythmias. Kalyanam Shivkumar
10:15 – 10:30 AM		AUTONOMIC GANGLIA AND THEIR ROLE IN AF Relationship between signal morphology and autonomic status in humans. Stavros Stavrakis
10:30 – 10:45 AM		CARDIONEUROABLATION ASSOCIATED WITH PVI New data on the contribution of cardioneuroablation to PVI José Carlos Pachón
10:45 – 11:00 AM		THE VEIN OF MARSHALL AND ITS CONTRIBUTION TO AF A review of scientific data. Miguel Valderrábano
11:00 – 11:15 AM		BACHMANN’S BUNDLE AND ITS ROLE IN AF Its anatomy, physiology, and contribution to arrhythmias. Natasja de Groot
11:15 – 11:30 AM		LEFT BUNDLE BRANCH PACING Definitions, techniques, and endpoints. Gaurav Upadhyay
11:30 – 12:00 PM		Panel Discussion with Q&A Session
12:00 – 1:00 PM		Lunch and Exhibits
1:00 – 3:00 PM		SESSION VIII: EMERGING ABLATION TECHNIQUES AND NOVEL THERAPIES Moderators: David Haines and Elad Anter
1:00 – 1:15 PM		OPTOGENETIC SENSORS AND ACTUATORS FOR TREATING ARRHYTHMIAS Use of optogenetics for the study and treatment of arrhythmias. Lior Gepstein
1:15 – 1:30 PM		IMMUNE RESPONSE MODULATION IN ARVC TREATMENT New data on immune mechanisms in ARVC and drug candidates. Jeffery Saffitz
1:30 – 1:45 PM		ALCOHOL ABLATION OF ARRHYTHMIAS The future of alcohol ablation—is it a bridge to more effective ablation technologies or a viable stand-alone adjunctive? Miguel Valderrábano
1:45 – 2:00 PM		INTEGRATION OF HIGH-RES MAPPING AND ABLATION IN A SINGLE CATHETER Clinical experience with a lattice catheter (an Affera technology). Josef Kautzner
2:00 – 2:15 PM		THE FUTURE OF CATHETER ABLATION The disproportional greater success in efforts placed in advancing ablation technologies compared to mapping technologies and the potential impact on future directions. David Callans
2:15 – 2:45 PM		Panel Discussion with Q&A Session
2:45 – 3:00 PM		Closing Thoughts and Farewell Elad Anter, Pierre Jaïs, and Natasja de Groot

Faculty

Course Founder and Director
Elad Anter, MD Director, Cardiac Electrophysiology Institute Shamir Medical Center, Tel Aviv University Tel Aviv, Israel
Course Co-Directors
Pierre Jaïs, MD Head, Electrophysiology Unit General Director, LIRYC University Professor in Cardiology and Cardiac Electrophysiology Bordeaux University Hospital Bordeaux, France		Natasja de Groot, MD, PhD Senior Cardiologist–Electrophysiologist Medical Delta Professor Erasmus Medical Center Rotterdam, The Netherlands
Faculty
Meir Bar-Tal, MSc Core Technology Director Biosense Webster, Inc. Yokneam, Israel		Stavros Stavrakis, MD, PhD University of Oklahoma Oklahoma City, OK, USA
Omer Berenfeld, PhD University of Michigan Ann Arbor, MI, USA		Decebal Gabriel Lațcu, MD Centre Hospitalier Princesse Grace MONACO
David Callans, MD University of Pennsylvania Health System Philadelphia, PA, USA		Sanjiv Narayan, MD Stanford Healthcare Stanford, CA, USA
Edward Ciaccio, PhD Columbia University New York, NY, USA		Andrea Natale, MD Texas Cardiac Arrhythmia Institute Austin, TX, USA
Kevin Donahue, MD University of Massachusetts Medical School Worcester, MA, USA		José Carlos Pachón, MD University of São Paulo São Paulo, Brazil
Olaf Dössel, MD Karlsruhe Institute of Technology Karlsruhe, Germany		Yoram Rudy, PhD Washington University in St. Louis St. Louis, MO, USA
Vadim Fedorov, PhD The Ohio State University College of Medicine Columbus, OH, USA		Jeffery Saffitz, MD, PhD Beth Israel Deaconess Medical Center Boston, MA, USA
Lior Gepstein, MD Sohnis Family Research Laboratory for Cardiac Electrophysiology & Regenerative Medicine Lab Technion’s Rappaport Faculty of Medicine Care Campus Haifa, Israel		Kalyanam Shivkumar, MD, PhD UCLA Medical Center Los Angeles, CA, USA
David Haines, MD William Beaumont Hospital Royal Oak, MI, USA		Bruce Smaill, PhD Auckland Bioengineering Institute Auckland, New Zealand
Michel Haïssaguerre, MD, PhD Bordeaux University Hospital Bordeaux, France		Peter Spector, MD University of Vermont Medical Center Burlington, VT, USA
Warren “Sonny” Jackman, MD University of Oklahoma Oklahoma City, OK, USA		Natalia Trayanova, PhD Johns Hopkins University Baltimore, MD, USA
Jérome Kalifa, MD Co-founder and CMO at Volta Medical Brown University Providence, RI, USA		Miguel Valderrábano, MD Houston Methodist Weill Cornell Medical College Houston, TX, USA
Josef Kautzner, MD, PhD Institute for Clinical and Experimental Medicine (IKEM) Charles University Medical School Prague, Czech Republic		Pascal Van Dessel, MD Thoraxcentre Twente Enschede, The Netherlands
Steven Kim, MSEE Senior Director of Clinical Research, Abbott St Paul, MN, USA		Edward Vigmond, PhD Bordeaux University Hospital Bordeaux, France
André Kléber, MD Visiting Professor of Pathology Harvard University Cambridge, MA, USA		Gaurav Upadhyay, MD University of Chicago Medicine Chicago, IL, USA
Zachary Koch, CCDS, CEPS Clinical Director, BioSig Technologies Westport, CT, USA		Paul Wang, MD Stanford Healthcare Stanford, CA, USA

ACTIVITY DESCRIPTION

The purpose of this educational activity is to provide comprehensive education on fundamental electrophysiology concepts ranging from basic science to signal processing engineering and innovations in electrophysiology. The atmosphere will encourage open discussions and an exchange of ideas aimed at reducing barriers and providing solutions to fundamental constraints.

TARGET AUDIENCE

This course has been designed for electrophysiologists, fellows, cardiologists, biomedical engineers, scientists, and associated physicians and allied health care professionals.

Learning Objectives

At the conclusion of this educational course, participants should be able to:

Assess Fundamentals of Electrical Propagation and Conduction Block.
Review Challenges and Solutions of Electrogram Recordings.
Examine Electrical Propagation During Ventricular Fibrillation.
Evaluate Emerging Technologies and Review Advancements in Procedural Approaches.
Assess Computational Models and Artificial Intelligence
Examine Anatomy, Physiology, and Pacing.
Discussion Emerging Ablation Techniques and Novel Therapies.

ACTIVITY GOAL

This activity is designed to address the following ABMS/IOM competencies: Patient Care, Medical Knowledge, and Practice-based Learning.

ACCREDITATION

This activity has been planned and implemented by MediaSphere Medical and Ciné-Med.
Ciné-Med is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.

Physicians: Ciné-Med designates this live activity for a maximum of 16 AMA PRA Category 1 Credit(s)™. Physicians should claim only the number of credits commensurate with the extent of their participation in the activity.

Nurses: Ciné-Med designates this activity for 16 Contact Hours for nurses.

Claiming CME Certificates

cme Signals Summit 2022 is CME-accredited for Onsite and Virtual attendees.
At the conclusion of the Signals Summit, an email will be issued that provides direct access to the post-activity CME form to claim credits for attendance. Additionally, the Claim CME Credit form will be accessible directly on the conference website.

1 CME Certificate is supplied electronically for the cumulative CME Credits earned commensurate with the extent of participation within the Signals Summit as an attendee.

DISCLOSURE POLICY

MediaSphere Medical and Ciné-Med adhere to accreditation requirements regarding industry support of continuing medical education. Disclosure of the planning committee and faculty’s commercial relationships will be made known at the activity on course handouts and during faculty presentations. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations.

All MediaSphere Medical and Ciné-Med employees in control of content have indicated that they have no relevant financial relationships to disclose.

It is the policy of MediaSphere Medical and Ciné-Med to ensure balance, independent objectivity, and scientific rigor in all its supported educational programs. All faculty members participating in educational activities are required to disclose to the program audience any real or apparent conflicts of interest present within the past 12 months.

MediaSphere Medical and Ciné-Med have implemented a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners. Faculty disclosures will be made available at the time of the Signals Summit.

Non-Endorsement Statement

MediaSphere Medical and Ciné-Med verify that sound education principles have been demonstrated in the development of this educational offering as evidenced by a review of its objectives, teaching plan, faculty, and activity evaluation process. MediaSphere Medical and Ciné-Med do not endorse or support the actual opinions or material content as presented by the speaker(s) and/or sponsoring organization.

December 2
December 3

December 2
December 3

Day 1: Friday, December 2, 2022

*Times listed are in Central Standard Time

7:55 – 8:00 AM		Welcome / Introduction / Opening Remarks Elad Anter
8:00 – 10:00 AM		SESSION I: FUNDAMENTALS OF ELECTRICAL PROPAGATION Moderator: Natasja de Groot and David Callans
8:00 – 8:15 AM		PRINCIPLES OF CARDIAC CONDUCTION DEDUCED FROM EXPERIMENTAL OBSERVATIONS Andre Kleber
8:15 – 8:30 AM		MECHANISMS AND SIGNALS OF SLOW CONDUCTION IN THE HEART Yoram Rudy
8:30 – 8:45 AM		3D ACTIVATION IN REGIONS OF ELECTRICAL DISCONTINUITY Bruce Smaill
8:45 – 9:00 AM		3D ACTIVATION IN AF Vadim Fedorov
9:00 – 9:15 AM		CONTRIBUTION OF HETEROGENICITY IN REPOLARIZATION FOR ARRHYTHMOGENESIS Kevin Donahue
9:15 – 9:30AM		ELECTROGENESIS OF CARDIAC BIOPOTENTIALS Kalyanam Shivkumar
9:30 – 10:00 AM		Panel Discussion with Q&A Session
10:00 – 10:15 AM		Break
10:15 AM – 12:30 PM		SESSION II: ELECTROGRAM RECORDING: CHALLENGES AND SOLUTIONS Moderator: Pascal Van Dessel and Warren Jackman
10:15 – 10:30 AM		UNIPOLAR, BIPOLAR, OMNIPOLAR, AND LAPLACIAN ELECROGRAMS Pascal Van Dessel
10:30 – 10:45 AM		CHALLENGES IN ACCURATE MEASUREMENT OF ACTIVATION TIMES Warren Jackman
10:45 – 11:00 AM		TRANSLATING CONDUCTION VELOCITY MEASUREMENTS FROM 2D TO 3D Edward Vigmond
11:00 – 11:15 AM		METHODOLOGICAL CONSIDERATIONS IN MAPPING FIBRILLATORY RHYTHMS Omer Berenfeld
11:15 – 11:30 AM		INSIGHTS FROM HIGH-RES, HIGH-DENSITY MAPPING OF AF IN HUMANS Natasja de Groot
11:30 – 11:45 AM		MAPPING WITH PACING FORM MULTIPLE WAVEFRONT IMPROVES SUBSTRATE CHARECTERIZATION OF VT ISTHMUS SITES Natalia Trayanova
11:45 – 12:00 PM		SIGNAL RECORDINGS: IDEAS TO IMPROVE CATHETER DESIGNS Olaf Dössel
12:00 – 12:30 PM		Panel Discussion with Q&A Session
		*Special Virtual Case Theater Session During On-Site Lunch Break in Chicago
12:30 – 1:10 PM		AFib Workflow with the OCTARAY™ Mapping Catheter and TRUEref™ Technology Joshua Silverstein Allegheny General Hospital, Pittsburgh, PA Session Description This Virtual Case Theater Session, exclusive to attendees of the live stream, features a pre-recorded procedure performed by Dr. Joshua Silverstein of Allegheny General Hospital, Pittsburgh, PA. Dr. Silverstein will address attendee submitted questions at the conclusion of the case demonstration, live and in real-time. Virtual attendees are encouraged to submit questions directly to Dr. Jose Silverstein throughout the duration of the Session.
1:10 – 1:15 PM		Break
1:15 – 2:15 PM		SESSION III: MARK E. JOSEPHSON MEMORIAL LECTURE Moderator: Elad Anter and Natasja de Groot
1:15 – 1:45 PM		ELECTRICAL PROPAGATION IN VENTRICULAR FIBRILLATION Michel Haïssaguerre
1:45 – 2:15 PM		Panel Discussion with Q&A Session
2:15 – 4:15 PM		SESSION IV: EMERGING TECHNOLOGIES IN SIGNAL RECORDING AND MAPPING Moderators: David Haines, Peter Spector, and Edward Ciaccio
2:15 – 2:25 PM		IMPLEMENTING FILTERS TO IMPROVE SIGNAL RECORDINGS Zach Koch
2:25 – 2:35 PM		NEAR FIELD DETECTION: RESOLVING LOCAL CONDUCTANCE IN THE SUBSTRATE Steven Kim
2:35 – 2:45 PM		ROLE OF SPATIOTEMPORAL ELECTROGRAM PROPAGATION IN AF MAPPING Jérome Kalifa
2:45 – 2:55 PM		ELECTROGRAPHIC FLOW MAPPING IN PERSISTENT AF David Haines
2:55 – 3:05 PM		A NEW MAPPING APPROACH FOR IMPROVED SCAR DETECTION Andrea Natale
3:05 – 3:15 PM		MAPPING AND IDENTIFYING ABLATION TARGETS DURING AF Decebal Gabriel Lațcu
3:15 – 3:45 PM		THE CHALLENGES OF AF MAPPING Peter Spector
3:45 – 4:15 PM		Panel Discussion with Q&A Session
4:15 – 4:30 PM		Break
4:30 – 5:30 PM		SESSION V: RECORDED CASES Moderators: Josef Kautzner, David Callans, and Elad Anter
		ABLATION APPROACH OF PERSISTENT AF WITH PFA Pierre Jaïs
		CARDIAC NEUROMODULATION OF VASOVAGAL SYNCOPE José Carlos Pachón
		ALCOHOL ABLATION OF PVC/VT Miguel Valderrábano

Day 2: Saturday, December 3, 2022

*Times listed are in Central Standard Time

8:15 – 9:45 AM		SESSION VI: COMPUTATIONAL MODELS AND SIGNAL ANALYSIS Moderators: Paul Wang, Edward Vigmond, and Edward Ciaccio
8:15 – 8:30 AM		COMPUTATIONAL APPROACHES FOR DIFFERENTIATING NEAR-FIELD FROM FAR-FIELD POTENTIALS Elad Anter
8:30 – 8:45 AM		COMPUTATIONAL MODELS OF AF TO GUIDE THERAPY Sanjiv Narayan
8:45 – 9:00 AM		STRATEGIES TO ADDRESS GAPS IN UNDERSTANDING ELECTRICAL SIGNALS FROM MAPPING, WEARABLE, AND IMPLANTABLE DEVICES Paul Wang
9:00 – 9:15 AM		DEEP LEARNING FOR RAPID CREATION OF CHAMBER GEOMETRY Meir Bar-Tal
9:15 – 9:45 AM		Panel Discussion with Q&A Session
9:45 – 10:00 AM		Break
10:00 – 12:00 PM		SESSION VII: ANATOMY, PHYSIOLOGY, AND PACING ABLATION Moderators: Kalyanam Shivkumar and David Haines
10:00 – 10:15 AM		ANATOMY AND ELECTROPHYSIOLOGY OF THE HIS–PURKINJE NETWORK Kalyanam Shivkumar
10:15 – 10:30 AM		AUTONOMIC GANGLIA AND THEIR ROLE IN AF Stavros Stavrakis
10:30 – 10:45 AM		CARDIONEUROABLATION ASSOCIATED WITH PVI New data on the contribution of cardioneuroablation to PVI José Carlos Pachón
10:45 – 11:00 AM		THE VEIN OF MARSHALL AND ITS CONTRIBUTION TO AF A review of scientific data. Miguel Valderrábano
11:00 – 11:15 AM		BACHMANN’S BUNDLE AND ITS ROLE IN AF Its anatomy, physiology, and contribution to arrhythmias. Natasja de Groot
11:15 – 11:30 AM		LEFT BUNDLE BRANCH PACING Definitions, techniques, and endpoints. Gaurav Upadhyay
11:30 – 12:00 PM		Panel Discussion with Q&A Session
		*Special Virtual Case Theater Session During On-Site Lunch Break in Chicago
12:00 – 12:45 PM		Paroxysmal AF with FARAPULSE PFA Prof. Tobias Reichlin, MD and Prof. Laurent Roten, MD Inselspital Hospital Bern Bern, Switzerland Session Description This Virtual Case Theater Session, exclusive to attendees of the live stream, features a recorded paroxysmal AF case performed with FARAPULSE PFA by Professor Tobias Reichlin and Professor Laurent Roten of Inselspital Hospital Bern.
12:45 – 1:00 PM		Break
1:00 – 3:00 PM		SESSION VIII: EMERGING ABLATION TECHNIQUES AND NOVEL THERAPIES Moderators: David Haines and Elad Anter
1:00 – 1:15 PM		OPTOGENETIC SENSORS AND ACTUATORS FOR TREATING ARRHYTHMIAS Lior Gepstein
1:15 – 1:30 PM		IMMUNE RESPONSE MODULATION IN ARVC TREATMENT Jeffery Saffitz
1:30 – 1:45 PM		ALCOHOL ABLATION OF ARRHYTHMIAS Miguel Valderrábano
1:45 – 2:00 PM		INTEGRATION OF HIGH-RES MAPPING AND ABLATION IN A SINGLE CATHETER Josef Kautzner
2:00 – 2:15 PM		THE FUTURE OF CATHETER ABLATION David Callans
2:15 – 2:45 PM		Panel Discussion with Q&A Session
2:45 – 3:00 PM		Closing Thoughts and Farewell

Agenda - Signals Summit 2022

Friday, December 2, 2022

Agenda

Signals Summit

Video Library >>